Search
for
Sort by
Research 841–870 of 1000+
- EFFICACY AND SAFETY OF LOW-DOSE ORAL MINOXIDIL IN THE TREATMENT OF ANDROGENETIC ALOPECIA – A LITERATURE REVIEW
- Analysing efficacy of low-dose oral minoxidil, topical minoxidil, and platelet-rich plasma with topical minoxidil combination in patients with androgenetic alopecia: a randomized controlled observer blinded trial
- JAAD Game Changers: Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients
- 513 Demonstration of hair health benefits using an oral supplement
- Evaluation of Clinical and Oral Findings in Patients with Epidermolysis bullosa
- Regulatory mechanisms of LGR4 on cancer and cancer stem cell properties
- Expression of Plectin-1 and Trichohyalin in Human Tongue Cancer Cells
- The Chinese herb Xiaoaiping protects against breast cancer chemotherapy-induced alopecia and other side effects: a randomized controlled trial
- Mucocutaneous Side Effects of Antineoplastic Drugs Used in Cancer Therapy in Erbil
- 2022 Update on Prostate Cancer Epidemiology and Risk Factors—A Systematic Review
- Epigenetics of Colorectal Cancer
- Multicentric parallel phase II trial of the polo-like kinase 1 inhibitor BI 2536 in patients with advanced head and neck cancer, breast cancer, ovarian cancer, soft tissue sarcoma and melanoma. The first protocol of the European Organization for Research and Treatment of Cancer (EORTC) Network Of Core Institutes (NOCI)
- Chemotherapy-induced dermatological toxicity: frequencies and impact on quality of life in women’s cancers. Results of a prospective study
- Newly Developed Targeted Therapies Against the Androgen Receptor in Triple-Negative Breast Cancer: A Review
- PROTACs: A novel strategy for cancer drug discovery and development
- Avaliação dos efeitos adversos clínicos e alterações laboratoriais em pacientes com acne vulgar tratados com isotretinoína oral
- Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib and Sorafenib in Korea
- Teriflunomide: A Once-daily Oral Medication for the Treatment of Relapsing Forms of Multiple Sclerosis
- The role of dermocosmetics in the management of cancer-related skin toxicities: international expert consensus
- Toxicity of repeated oral intake of organic selenium, inorganic selenium, and selenium nanoparticles: A review
- Clinicopathologic Characteristics and Response to Treatment of Persistent Chemotherapy-Induced Alopecia in Breast Cancer Survivors
- Retrospective cohort study of CDK4/6-inhibitor-induced alopecia in breast cancer patients
- Severe skin toxicity during whole-brain radiotherapy, targeted therapy, and additional drug intake including St. John’s wort skin oil
- Drug interactions between common dermatological medications and the oral anti-COVID-19 agents nirmatrelvir-ritonavir and molnupiravir
- Permanent chemotherapy-induced alopecia after hematopoietic stem cell transplantation treated with low-dose oral minoxidil
- Ottawa, Ontario, Canada, February 13–16, 2013
- The Effect of Oral Care Foams and a Spray on Salivary pH Changes after Exposure to Acidic Beverages in Young Adults
- Orthostatic symptoms in women treated with low-dose oral minoxidil in the absence of overt hypotension: Implications for clinical practice
- Optimizing hair care products and practices for Black patients with breast cancer: One size does not fit all
- Medical, dental and dual-degree ‘Oral-Maxillofacial’ signatures — what have I seen over the past 22 years?